Kaneshige Terumi, Arata Naoko, Harada Shohei, Ohashi Toshinori, Sato Shiori, Umehara Nagayoshi, Saito Takakazu, Saito Hidekazu, Murashima Atsuko, Sago Haruhiko
Center of Maternal-Fetal, Neonatal and Reproductive Medicine (T.K., N.A., S.S., N.U., T.S., H.Sai., A.M., H.Sag), Division of Neonatal Screening (S.H.), National Center for Child Health and Development, Tokyo 1578535, Japan; and Hitachi Chemical Corporation (S.H., T.O.), Tokyo 1006606, Japan.
J Clin Endocrinol Metab. 2015 Mar;100(3):E469-72. doi: 10.1210/jc.2014-2731. Epub 2014 Dec 29.
Reports of hypothyroidism after hysterosalpingography (HSG) using lipiodol are emerging. The present study was designed to investigate the changes in serum iodine concentration (SIC), urinary iodine concentration/creatinine excretion (UI/Cr), and thyroid function before and after HSG using lipiodol.
The prospective observation study included 22 infertile euthyroid women with no previous history of thyroid disease. All underwent HSG between April 2007 and August 2008 at our institution. We examined SIC, UI/Cr, and thyroid function before HSG, and at 4, 8, 12, and 24 weeks, and 9-12 months after HSG.
The median value of SIC and UI/Cr peaked at 4 weeks after HSG and remained at significantly high levels at 8, 12, and 24 weeks post-HSG compared with pre-HSG. In sync with the increase of iodine, the mean level of TSH significantly increased at 4, 8, 12, and 24 weeks post-HSG compared with pre-HSG. After 24 weeks, differences in SIC, UI/Cr, and TSH levels before and after HSG became nonsignificant. The mean value of free triiodothyronine and free thyroxine showed no significant difference at any of the time points compared with pre-HSG. Three cases (13.6%) showed transient high TSH (>5 μIU/L) with normal thyroid hormones at 4 or 8 weeks after HSG.
Thyroid monitoring should be conducted in the first 4-8 weeks after HSG using lipiodol and attention to thyroid dysfunction should be paid for up to 6 months after the procedure due to the possibility of excess iodine.
使用碘油进行子宫输卵管造影(HSG)后出现甲状腺功能减退的报道逐渐增多。本研究旨在调查使用碘油进行HSG前后血清碘浓度(SIC)、尿碘浓度/肌酐排泄率(UI/Cr)及甲状腺功能的变化。
这项前瞻性观察研究纳入了22例无甲状腺疾病史的不孕且甲状腺功能正常的女性。2007年4月至2008年8月期间,所有患者均在本机构接受了HSG检查。我们在HSG前、HSG后4周、8周、12周、24周以及9至12个月时检测了SIC、UI/Cr及甲状腺功能。
SIC和UI/Cr的中位数在HSG后4周达到峰值,与HSG前相比,在HSG后8周、12周和24周时仍显著处于高水平。与碘增加同步,HSG后4周、8周、12周和24周时促甲状腺激素(TSH)的平均水平与HSG前相比显著升高。24周后,HSG前后SIC、UI/Cr和TSH水平的差异不再显著。与HSG前相比,在任何时间点游离三碘甲状腺原氨酸和游离甲状腺素的平均值均无显著差异。3例患者(13.6%)在HSG后4周或8周时出现短暂性高TSH(>5 μIU/L),甲状腺激素水平正常。
使用碘油进行HSG后的前4至8周应进行甲状腺监测,由于存在碘过量的可能性,术后6个月内都应关注甲状腺功能障碍。